These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11692848)

  • 1. [Dual infection with HIV and HCV. Focus on antiviral therapy].
    MMW Fortschr Med; 2001 Oct; 143(40):54. PubMed ID: 11692848
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-alpha in treatment of chronic hepatitis C in co-infected HIV-patients in combination with ribavirin and as a pre-load therapy in treatment-naive HIV-positive patients. 8th European Conference on Clinical Aspects and Treatment of HIV Infection (8th ECCATH), 29-31 October, Athens Greece.
    Tossing G
    Eur J Med Res; 2002 Jan; 7(1):44-6. PubMed ID: 11827840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boceprevir for HCV in patients with HIV: where next?
    Osinusi A; Naggie S
    Lancet Infect Dis; 2013 Jul; 13(7):563-4. PubMed ID: 23768748
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pegylated interferon plus ribavirin in chronic hepatitis C. More than half of patients show a lasting response].
    Zeuzem S
    MMW Fortschr Med; 2002 Feb; 144(8):30-4. PubMed ID: 11910820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Groundbreaking new data for HIV and hepatitis B and C. What will change in 2010?].
    Jablonowski H; Mauss S
    MMW Fortschr Med; 2010 Apr; 152(17):26. PubMed ID: 20509255
    [No Abstract]   [Full Text] [Related]  

  • 6. Open, randomized, multicentre italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART.
    Cargnel A; Angeli E; Mainini A; Gubertini G; Giorgi R; Schiavini M; Duca P;
    Antivir Ther; 2005; 10(2):309-17. PubMed ID: 15865225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage.
    Moreno A; Quereda C; Fortún J; Bárcena R; Pérez-Elías MJ; Casado JL; Rodríguez-Sagrado MA; Mateos ML; Blesa C; Moreno S
    AIDS; 2010 May; 24(8):1231-3. PubMed ID: 20421744
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step.
    Manns MP; Wedemeyer H
    JAMA; 2004 Dec; 292(23):2909-13. PubMed ID: 15598923
    [No Abstract]   [Full Text] [Related]  

  • 9. Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV.
    Rivero-Juarez A; Lopez-Cortes LF; Girón-Gonzalez JA; Pineda JA; Rivero A;
    Lancet Infect Dis; 2014 Jan; 14(1):13-14. PubMed ID: 24355031
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic hepatitis C and HIV. Current therapeutic options].
    Mauss S
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():46-9. PubMed ID: 11373779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
    D'Offizi G; Martini F; Rozera G; Abbate I; Capobianchi MR; Narciso P; Dianzani F
    AIDS; 2008 Jan; 22(2):321. PubMed ID: 18097242
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination treatment for chronic HCV hepatitis in lymphangioleiomyomatosis: first case report.
    Bartalesi F; Camiciottoli G; Corti G; Maluccio NM; Biliotti E; Bartoloni A; Taliani G
    J Chemother; 2009 Feb; 21(1):110-1. PubMed ID: 19297285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress in the treatment of hepatitis B and C co-infection in HIV patients].
    Mauss S
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():27-9. PubMed ID: 15373041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increasing chances. Effective HCV therapy lowers mortality of HIV infection].
    MMW Fortschr Med; 2003 Jun; 145(26):53. PubMed ID: 12916340
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results.
    Lacombe K; Valin N; Stitou H; Gozlan J; Thibault V; Boyd A; Poirier JM; Meynard JL; Valantin MA; Bottero J; Girard PM
    AIDS; 2013 May; 27(8):1356-9. PubMed ID: 23925383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.
    Bräu N
    J Antimicrob Chemother; 2005 Dec; 56(6):991-5. PubMed ID: 16308419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin.
    Soriano V; Miralles C; Berdún MA; Losada E; Aguirrebengoa K; Ocampo A; Arazo P; Cervantes M; de los Santos I; San Joaquín I; Echeverria S; Galindo MJ; Asensi V; Barreiro P; Sola J; Hernandez-Burruezo JJ; Guardiola J; Blanco F; Martin-Carbonero L; García-Samaniego J; Nuñez M;
    Antivir Ther; 2007; 12(4):469-76. PubMed ID: 17668555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
    Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
    AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL.
    Lo Nigro L; La Spina M; Mirabile E; Pisana P; Schilirò G; Guardo P
    Pediatr Blood Cancer; 2004 Aug; 43(2):185. PubMed ID: 15236293
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort.
    Wojcik K; Vogel M; Voigt E; Speidel N; Kalff JC; Goldmann G; Oldenburg J; Sauerbruch T; Rockstroh JK; Spengler U
    AIDS; 2007 Jun; 21(10):1363-5. PubMed ID: 17545715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.